Corteva, Inc.

Corteva Agriscience is a pure-play global agricultural technology company formed in 2019 from the merger and subsequent spin-off of Dow and DuPont's agricultural divisions. Listed on the NYSE CTVA, Corteva combines world-class seed genetics—particularly in corn and soybeans—with a rapidly growing portfolio of proprietary crop protection chemicals and biologicals. The company operates approximately 100 manufacturing sites and 120+ R&D facilities across 110 countries with 22,000 employees and US$17.4 billion in 2025 net sales.

• Seed Genetics & Traits: Pioneer brand corn, soybean, sunflower, canola, and sorghum seeds with advanced genetic traits for insect resistance, herbicide tolerance, and high-yield germplasm • Crop Protection Chemicals: Proprietary herbicides including Arylex and Rinskor active ingredients, insecticides Isoclast, Jemvelva, and fungicides Zorvec, Vessarya • Biologicals: Biostimulants including Utrisha N nitrogen-fixing bacteria, biofungicides, and bionematicides derived from microbial fermentation • Seed-Applied Technologies: Lumivia and Lumiderm seed treatments providing early-season insect and disease protection • Digital Agriculture: Granular farm management software and Corteva Agriscience Digital platform for precision planting and field monitoring • Pasture & Range Management: Herbicide solutions for grassland, rangeland, and non-crop vegetation management

Market Position & Financial Strength

Corteva Agriscience delivered exceptional 2025 results with US$17.4 billion in net sales (4% organic growth), operating EBITDA surging 14% to US$3.85 billion, and net income leaping 40% to US$1.2 billion. The Seed segment achieved 5% organic growth from expanded North American and Brazilian corn acreage, while Crop Protection volumes increased 5% driven by new mode-of-action molecules and surging biologicals demand. The Price-for-Value strategy successfully offset raw material cost pressures.

Technological Innovation & Moat

Corteva's innovation engine spans proprietary seed breeding, synthetic chemistry discovery, and biological fermentation. The dual strength in seeds and crop protection creates unique synergies—seed-applied technologies and herbicide-tolerant trait systems are co-developed across divisions. The Utrisha N biostimulant exemplifies Corteva's biologicals strategy: a naturally occurring nitrogen-fixing bacterium that delivers measurable yield benefits while reducing carbon footprint by over 400,000 tonnes CO2e in European maize over four years.

Sustainability & Future Outlook

Corteva's 2030 sustainability goals target improved nitrogen use efficiency, reduced pesticide environmental impact, and enhanced soil conservation. The biologicals portfolio represents the company's highest-growth opportunity amid tightening synthetic chemical regulations. Key risks include concentration in North/South American row crop cycles and potential activist investor pressure. VerityRank Score: 89/100